Optimizing data-flow in Binary Neural Networks

Autor: Vorabbi, L., Maltoni, D., Santi, S.

Binary Neural Networks (BNNs) can significantly accelerate the inference time of a neural network by replacing its expensive floating-point arithmetic with bitwise operations. Most existing solutions, however, do not fully optimize data flow through

Externí odkaz: http://arxiv.org/abs/2304.00952

Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States.

Autor: Frech, Feride H., Li, G., Juday, T., Ding, Y., Mattke, S., Khachaturian, A., Rosenberg, A. S., Ndiba-Markey, C., Rava, A., Batrla, R., De Santi, S., Hampel, H.

Publikováno v: Journal of Prevention of Alzheimer's Disease; Aug2024, Vol. 11 Issue 4, p983-991, 9p

Functional Effect of Lesser Yam Symbiotic Yoghurt on Hypercholesterolemia Wistar Rats

Autor: Rosida, Santi S. S.

Publikováno v: MATEC Web of Conferences, Vol 372, p 02001 (2022)

Synbiotic lesser yam yoghurt is fermented drink made from the mixture of cow’s milk and lesser yam extract which has functional benefits. Lesser yam yoghurt contains lactic acid bacteria, lactic acid, inulin, and soluble fiber which can improve the

Externí odkaz: https://doaj.org/article/f3b709ac9a8c4c74aa665c55fc373881

Defective collagen VI α6 chain expression in the skeletal muscle of patients with collagen VI-related myopathies

Autor: Tagliavini, F., Pellegrini, C., Sardone, F., Squarzoni, S., Paulsson, M., Wagener, R., Gualandi, F., Trabanelli, C., Ferlini, A., Merlini, L., Santi, S., Maraldi, N.M., Faldini, C., Sabatelli, P.

Publikováno v: In BBA - Molecular Basis of Disease September 2014 1842(9):1604-1612

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

Autor: Simuni, T, Merchant, K, Brumm, MC, Cho, H, Caspell-Garcia, C, Coffey, CS, Chahine, LM, Alcalay, RN, Nudelman, K, Foroud, T, Mollenhauer, B, Siderowf, A, Tanner, C, Iwaki, H, Sherer, T, Marek, K, Seibyl, J, Coffey, C, Tosun-Turgut, D, Shaw, LM, Trojanowski, JQ, Singleton, A, Kieburtz, K, Toga, A, Galasko, D, Poewe, W, Poston, K, Bressman, S, Reimer, A, Arnedo, V, Clark, A, Frasier, M, Kopil, C, Chowdhury, S, Casaceli, C, Dorsey, R, Wilson, R, Mahes, S, Salerno, C, Ahrens, M, Brumm, M, Cho, HR, Fedler, J, LaFontant, D-E, Kurth, R, Crawford, K, Casalin, P, Malferrari, G, Weisz, MG, Orr-Urtreger, A, Trojanowski, J, Shaw, L, Montine, T, Baglieri, C, Christini, A, Russell, D, Dahodwala, N, Giladi, N, Factor, S, Hogarth, P, Standaert, D, Hauser, R, Jankovic, J, Saint-Hilaire, M, Richard, I, Shprecher, D, Fernandez, H, Brockmann, K, Rosenthal, L, Barone, P, Espayc, A, Rowe, D, Marder, K, Santiago, A, Hu, S-C, Isaacson, S, Corvol, J-C, Martinez, JR, Tolosa, E, Tai, Y, Politis, M, Smejdir, D, Rees, L, Williams, K, Kausar, F, Richardson, W, Willeke, D, Peacock, S, Sommerfeld, B, Freed, A, Wakeman, K, Blair, C, Guthrie, S, Harrell, L, Hunter, C, Thomas, C-A, James, R, Zimmerman, G, Brown, V, Mule, J, Hilt, E, Ribb, K, Ainscough, S, Wethington, M, Ranola, M, Santana, HM, Moreno, J, Raymond, D, Speketer, K, Carvajal, L, Carvalo, S, Croitoru, I, Garrido, A, Payne, LM, Viswanth, V, Severt, L, Facheris, M, Soares, H, Mintun, MA, Cedarbaum, J, Taylor, P, Biglan, K, Vandenbroucke, E, Sheikh, ZH, Bingol, B, Fischer, T, Sardi, P, Forrat, R, Reith, A, Egebjerg, J, Hillert, GA, Saba, B, Min, C, Umek, R, Mather, J, De Santi, S, Post, A, Boess, F, Taylor, K, Grachev, I, Avbersek, A, Muglia, P, Tauscher, J

We examined 2-year longitudinal change in clinical features and biomarkers in LRRK2 non-manifesting carriers (NMCs) versus healthy controls (HCs) enrolled in the Parkinson’s Progression Markers Initiative (PPMI). We analyzed 2-year longitudinal dat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::57cb78cbdcff5c5771194646efb11352
http://hdl.handle.net/10044/1/101202